eMed and Nitra Secure Major Funding in Health Tech Sector
In March 2026, Miami-based eMed raised $200 million in a Series A funding round, while New York-based Nitra obtained $187 million, according to Dealbreaker. These rounds are part of several major funding announcements in the health tech industry, as detailed in the source material.
eMed’s Series A Funding Details
eMed, which offers GLP-1 programs for employers including at-home lab testing, health assessments, clinical review, medication management, weight and biomarker tracking, weekly check-ins, and 24/7 support, secured $200 million led by AON Consulting. Participants included former professional football player Tom Brady, Jeff Aronin of Paragon Biosciences, Ara Cohen of Knighthead Capital Management, and Antonio Gracias of Valor Equity Partners, among others. The financing aims to advance eMed’s agentic AI platform and support its balance sheet, as stated in the announcement from Dealbreaker.
Nitra’s Funding and Growth Plans
Nitra, which provides financial automation, access to pharmaceuticals and medical equipment, and AI agents for patient scheduling and insurance eligibility checks, raised $187 million with investors including Actions Capital, Comma Capital, Hyphen Capital, Mana Ventures, Necessary Ventures, New Enterprise Associates, Pantera Capital, Sazze Partners, and Soma Capital. This brings Nitra’s total capital raised to $205 million and equity to $90 million. The funds will accelerate AI development, expand the engineering team, and scale its operating system, according to the source.
Other Health Tech Funding Rounds
Grow Therapy, based in New York City, raised $150 million in a Series D round led by TCV and Growth Equity at Goldman Sachs Alternatives, with participation from BCI, Menlo Ventures, Sequoia, SignalFire, and Transformation Capital, bringing its total funding to $328 million. The money will support expansion into employer-sponsored mental health benefits, integration with primary care, and development of AI tools. Separately, Qualified Health secured $125 million in a Series B round led by New Enterprise Associates, with involvement from Transformation Capital, GreatPoint Ventures, Cathay Innovation, Menlo Ventures’ Anthology Fund, SignalFire, Frist Cressey Ventures, Flare Capital Partners, Healthier Capital, Town Hall Ventures, and Intermountain Ventures; this funding will deepen partnerships, accelerate AI deployments, and expand infrastructure for health systems adopting AI, as per Dealbreaker.
Context on Health Tech Investments
As widely known in the investment community, health tech funding often focuses on AI and administrative efficiencies, though these specifics are drawn directly from the source material.
